INTERNATIONAL PATENT: SPYRE THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS OF TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISEASES USING Α4Β7 BINDING ANTIBODY AND TL1A BINDING ANTIBODY"

GENEVA, April 20 -- SPYRE THERAPEUTICS, INC. (221 Crescent Street, Suite 105Waltham, Massachusetts 02453) filed a patent application (PCT/US2025/050223) for "METHODS OF TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISEASES USING Α4Β7 BINDING ANTIBODY AND TL1A BINDING ANTIBODY" on Oct 09, 2025. With publication no. WO/2026/080698, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SPENCER, Andrew G. (c/o Spyre Therapeutics, Inc.221 Crescent Street, Suite 105Waltham, Massachusetts 02453), YAN, Li (c/o Spyre Therapeutic...